Ellisa Cholapranee - Clearpoint Neuro General Secretary
| CLPT Stock | USD 13.38 0.29 2.12% |
Executive
Ellisa Cholapranee is General Secretary of Clearpoint Neuro
| Phone | 888 287 9109 |
| Web | https://www.clearpointneuro.com |
Clearpoint Neuro Management Efficiency
The company has return on total asset (ROA) of (0.3016) % which means that it has lost $0.3016 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8124) %, meaning that it created substantial loss on money invested by shareholders. Clearpoint Neuro's management efficiency ratios could be used to measure how well Clearpoint Neuro manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Reay MD | Sight Sciences | N/A | |
| Laura Romike | Outset Medical | N/A | |
| Sean Scanlan | Treace Medical Concepts | 42 | |
| Ezgi Yagci | Inspire Medical Systems | N/A | |
| William George | Electromed | 75 | |
| Alex CMA | LivaNova PLC | 55 | |
| Kevin Smith | Inogen Inc | 54 | |
| Taylor Ocasio | Tela Bio | N/A | |
| Mark Karshner | Orthopediatrics Corp | N/A | |
| Donna Shiroma | Avita Medical | 61 | |
| Terry Bromley | Avita Medical | N/A | |
| Jennifer Armstrong | Tela Bio | 55 | |
| Aaron Berutti | Treace Medical Concepts | 45 | |
| JD PMP | Avita Medical | N/A | |
| Daniel JD | Orthopediatrics Corp | 55 | |
| Taylor Erickson | Treace Medical Concepts | N/A | |
| Vijay Paliwal | Inogen Inc | N/A | |
| Christian MD | Cytosorbents Crp | N/A | |
| Philip Kowalczyk | LivaNova PLC | N/A | |
| Marcee Maroney | Pulmonx Corp | 55 | |
| Grgoire Ramade | Inogen Inc | 55 | |
Management Performance
| Return On Equity | -0.81 | ||||
| Return On Asset | -0.3 |
Clearpoint Neuro Leadership Team
Elected by the shareholders, the Clearpoint Neuro's board of directors comprises two types of representatives: Clearpoint Neuro inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Clearpoint. The board's role is to monitor Clearpoint Neuro's management team and ensure that shareholders' interests are well served. Clearpoint Neuro's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Clearpoint Neuro's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joseph Burnett, CEO President | ||
| Mazin Sabra, Chief Officer | ||
| Danilo DAlessandro, Chief Officer | ||
| Ellisa JD, General Secretary | ||
| Ellisa Cholapranee, General Secretary | ||
| Jeremy Stigall, Executive Delivery | ||
| Jacqueline Keller, Vice Marketing |
Clearpoint Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Clearpoint Neuro a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.81 | ||||
| Return On Asset | -0.3 | ||||
| Profit Margin | (0.60) % | ||||
| Operating Margin | (0.72) % | ||||
| Current Valuation | 352.63 M | ||||
| Shares Outstanding | 27.63 M | ||||
| Shares Owned By Insiders | 8.00 % | ||||
| Shares Owned By Institutions | 33.26 % | ||||
| Number Of Shares Shorted | 635.68 K | ||||
| Price To Earning | (3.36) X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Clearpoint Stock Analysis
When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.